🎉 Finosauras is now  SarasRead more
Piramal Pharma Ltd logo

Piramal Pharma Ltd

(NSE: PPLPHARMA)

Sector: Healthcare

Market Cap: 22344.66 Cr

166.28

-1.74 (-1.05%)

CMP

As on 16 Jan 2026, 03:30 pm

Open
168.40
High
169.08
Low
165.18
Close
166.28
Previous Close
168.02

Returns

PeriodReturn %
1 Month-2.75
3 Months-15.84
1 Year-29.84
5 Years--

Last updated on: 09/01/2026, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
Ca Alchemy Investments17.95%238,663,700
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund9.38%124,684,388
East Bridge Capital Master Fund I Ltd2%26,638,422
Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund1.1%14,558,720
The Hongkong And Shanghai Banking Corp.Ltd.0%1,332

Last updated on: 9/30/2025, 12:00:00 AM

Technical Data

No data available.

Last updated on: 16/01/2026, 3:30 pm

Latest Market News

Fundamental Data

Fundamental Analysis

P/E Ratio

31.67

P/B Ratio

2.88

PEG Ratio

0.56

ROE

9.83%

EPS

5.31

Dividend Yield

0.08%

Market Cap

22344.66 Cr

Sector

N/A

Last Updated: 16 Jan 2026, 02:30 pm

Loading peer comparison...

About : Piramal Pharma Ltd.

Incorporated Year

2020

City and State

Mumbai, Maharashtra

Listing Date

Director's Name

Jairaj Purandare

Revenue

5444.70 Cr

Net Profit

691.40 Cr

FAQs